Johnson & Johnson’s Post

View organization page for Johnson & Johnson, graphic

9,095,842 followers

"There’s a meaningful real-world impact to every decision we make in oncology.” Ekta, Director, New Product and Business Development Strategy, Oncology, discusses the differences between #BusinessDevelopment #careers on our team versus those in tech: https://bit.ly/4aRVWJM

  • No alternative text description for this image
Még Férreira

South America Legal and Compliance Manager | Mergers and Acquisitions (M&A) | Corporate Lawyer O&G | Energy | Contracts

1w

Johnson & Johnson has a division focused on oncology that integrates research and development of medicines for cancer treatment. This division is under the Janssen company, which is the pharmaceutical division of Johnson & Johnson. Johnson & Johnson Oncology invests in innovation to develop therapies that meet diverse oncological needs, covering areas such as breast, lung, prostate and hematological cancers, among others. The company is involved in several clinical studies and partnerships to advance more effective and personalized treatments. They also work on immunological and targeted therapies, with the goal of improving survival rates and quality of life for cancer patients.

Shanon Cooper

GenAI Business Strategist - $1 Billion in Sales

1w

If you have ever watched a loved one suffer the ravages of cancer, you know how important this work is. Thank you!

Rebecca Hayes

Regional Director - Central and East at Ridwell

1w

Great insight into a really interesting role!

See more comments

To view or add a comment, sign in

Explore topics